US Bancorp’s Tango Therapeutics TNGX Stock Holding History

US Bancorp’s Portfolio TNGX Stock Details TNGX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$1K	Buy	+48	New	+$668	﹤0.01%	3932
2025 Q4	–	Sell	-53	Closed	-$445	–	4199
2025 Q3	$445	Sell	53 -6,136	-99%	-$41.5K	﹤0.01%	3878
2025 Q2	$31.7K	Sell	6,189 -611	-9%	-$1.51K	﹤0.01%	2990
2025 Q1	$9.32K	Sell	6,800 -197	-3%	-$484	﹤0.01%	3459
2024 Q4	$21.6K	Buy	6,997 +6,732	+2,540%	+$31.3K	﹤0.01%	3124
2024 Q3	$2.04K	Sell	265 -302	-53%	-$2.88K	﹤0.01%	3780
2024 Q2	$4.87K	Buy	567 +103	+22%	+$796	﹤0.01%	3524
2024 Q1	$3.68K	Hold	464	–	–	﹤0.01%	3597
2023 Q4	$4.59K	Buy	+464	New	+$4.03K	﹤0.01%	3553

Other funds holding TNGX

RTW Investments New York $10B AUM 135.35% 1-Year Est. Return

Adage Capital Partners Boston, Massachusetts $64.8B AUM 42.7% 1-Year Est. Return

BCM

Boxer Capital Management San Diego, California $762M AUM 1,125.36% 1-Year Est. Return

TCM

TCG Crossover Management Palo Alto, California $3.5B AUM 1,165.83% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

FCM

Farallon Capital Management San Francisco, California $17.5B AUM 50.95% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Woodline Partners San Francisco, California $26.4B AUM 44.85% 1-Year Est. Return

Nextech Invest Zurich, Switzerland $1.42B AUM 304.47% 1-Year Est. Return

TGI

TRV GP IV Boston, Massachusetts $267M AUM 965.83% 1-Year Est. Return

US Bancorp's TNGX Position: Q1 2026 in Review

US Bancorp opened a new position in Tango Therapeutics (TNGX) in Q1 2026: 48 shares worth $1K. The stake represents ﹤0.01% of the portfolio and ranks #3932 among its holdings. This is a return to the name: US Bancorp previously reported a position in TNGX as recently as Q3 2025.

US Bancorp first reported a position in TNGX in Q4 2023 and has held it in 9 quarters since. The position peaked at $31.7K in Q2 2025. 194 funds tracked by Wall St. Rank hold TNGX as of Q1 2026.

US Bancorp held 48 shares of Tango Therapeutics worth $1K as of Q1 2026.
Tango Therapeutics was a new US Bancorp position in Q1 2026.
Tango Therapeutics made up ﹤0.01% of US Bancorp's portfolio in Q1 2026, its #3932 holding.
US Bancorp first reported a position in Tango Therapeutics in Q4 2023 and has held it in 9 quarters since.
US Bancorp's Tango Therapeutics position peaked at $31.7K in Q2 2025.
194 funds tracked by Wall St. Rank held Tango Therapeutics as of Q1 2026.

Based on US Bancorp's 13F filing for Q1 2026, filed 15 May 2026.